This is a kind reminder that the deadline (Feb 25th) for our early bird ticket is approaching. For those who are planning to attend China [email protected] Vienna, please register now to get your €150 off!
Explore alternative funding opportunities and how to enter a fast-growing healthcare market in 2019. We bring 100+ Chinese companies and investors seeking partnerships in biotech and pharma products. Meet more decision makers than you can in any event along the year!

Here are just a few of our newly confirmed speakers

Binhui Ni Managing Partner I-Bridge Capital
Geffrey Gao Executive VP/ Deputy GM Harbin Pharmaceutical Group
Olivier Reinhard VP, Global head of business development Sanofi
Dong Chen Director and China head of business development Jiangsu Hengrui Pharmaceutical
Hua Jiang VP (International business & strategy) Luye Pharma Group
Qun Dang VP, Global head of business development Qilu Pharmaceutical
Qingping Zeng President and CEO Fosun Orinove
Weimin Tang Global business head and Executive VP I-Mab BioPharma
John Xu CEO and co-founder Jemincare Therapeutics
Tom Du Medical Partner Shenzhen Share Capital
Ruyi He Chief Scientist SDIC Fund Management
Donald Xu Managing Partner Lynx Financial